Family Medicine Doctors in Pendleton, IN Accepting Medicare
8 Family Medicine doctors found. Showing 1 - 8
 Nathan James Stephens, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1251 Huntzinger Blvd Ste 100, Pendleton, IN 46064 Phone: 765-298-4567 Fax: 765-298-4568 |
Michael Meng, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Village Dr, Pendleton, IN 46064 Phone: 765-778-0913 |
Gary A Wright, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Village Dr, Pendleton, IN 46064 Phone: 765-778-0913 |
 Traci A Anderson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1251 Huntzinger Blvd Ste 100, Pendleton, IN 46064 Phone: 765-298-4567 Fax: 765-298-4568 |
Dr. Stephanie Jane Russ, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1251 S Huntzinger Blvd, Suite 100, Pendleton, IN 46064 Phone: 765-298-4567 Fax: 765-298-4568 |
Emily Elizabeth Musgrave, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3041 W Us Highway 36, Pendleton, IN 46064 Phone: 765-778-0000 |
Eric C Jones, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 138 W State St, Pendleton, IN 46064 Phone: 765-221-9413 Fax: 765-221-9418 |
Dr. Dennis Lee Fast, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Jh Walker Dr, Suite 110, Pendleton, IN 46064 Phone: 765-778-7534 Fax: 765-778-7535 |
News Archive
Polio elimination hindered by unvaccinated children in Pakistan and Afghanistan
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
Regeneron's ARCALYST prevents gout attacks in Phase 3 study of patients initiating allopurinol therapy
Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.
Big differences in VA care quality
Sloan Gibson, the acting head of the Department of Veterans Affairs, pledged to end delays in care for veterans Monday.
South Asian patients with CAD more likely to need repeat PCI procedures
South Asian patients with coronary artery disease were almost three times as likely to be readmitted to hospital for further interventional treatment to arterial plaque than their White European counterparts, according to research in the December issue of IJCP, the International Journal of Clinical Practice. They were also more likely to present as an emergency and require urgent treatment.
› Verified 2 days ago